West africa aims for pharmaceutical independence at Lomé summit

Lomé, August 13, 2026 — The choice is stark: continue relying on foreign drug imports or build a robust local pharmaceutical industry. This critical crossroads was the focus of a landmark gathering of medical and academic leaders across West Africa on August 12 at the Agora Senghor in Lomé, where a bold new health strategy for the subregion began to take shape.

The 21st edition of the West African Pharmaceutical Students Federation (FESPAO) Scientific and Cultural Conference sent a clear message: the next generation of medical professionals is no longer content with mere budget requests—they are demanding a fundamental shift in healthcare policy. The era of pharmacies acting solely as distribution centers is over. The future belongs to industrialization, genomic research, and the scientific validation of traditional knowledge.

Local Production: A National Security Priority

The COVID-19 pandemic and recent supply chain disruptions have exposed a harsh reality: dependence on imported medicines is not just an economic burden—it is a serious national security risk. This was the central argument driving discussions at the summit.

Professor Gado Tchangbédji, Togo’s Minister Delegate for Higher Education and Research, outlined the government’s new direction under President Faure Essozimna Gnassingbé: making innovation and local pharmaceutical production the cornerstone of West Africa’s defense against future health crises. To achieve this, the state is committing to substantial support for scientific cooperation and applied research.

Genomic Epidemiology and Indigenous Knowledge: The Keys to Self-Sufficiency

Relying on local production alone is insufficient if it means simply replicating foreign patents. True pharmaceutical sovereignty requires treatments tailored to the unique genetic and epidemiological profile of African populations—a demographic long overlooked in global clinical trials. This urgent need has placed “genomic epidemiology” at the heart of the Lomé conference agenda.

Alongside cutting-edge science, experts are advocating for the industrial valorization of traditional medicine. No longer confined to informal use, local pharmacopeia must undergo rigorous clinical testing to unlock and patent entirely new, Africa-born active molecules.

Redefining the Pharmacist’s Role in a New Era

Transforming ambition into reality demands more than policy statements—it requires a skilled workforce. Professor Tchin Darré, Togo’s Minister Delegate for Health and Dean of the Faculty of Health Sciences at the University of Lomé, emphasized the need for urgent academic reform. The West African pharmacist of tomorrow cannot remain a mere dispenser of pre-packaged medicines. This professional must evolve into a research scientist, an industrial leader, and an expert in validating traditional knowledge.

As deliberations continue in Lomé, the 21st FESPAO conference has set a decisive goal: turning academic discussions into enforceable public policies. The ultimate aim is to ensure universal healthcare access in West Africa is no longer contingent on factories located thousands of miles away from patients.

The stakes could not be higher. Without a strong local pharmaceutical industry and research rooted in African realities, West Africa will remain vulnerable to external solutions. In the face of future pandemics, this dependence could prove fatal. True health sovereignty will be determined by each nation’s ability to translate these resolutions into tangible action—so every patient on the continent can access medicines designed, validated, and produced locally.